MultiPlan (MPLN)
(Delayed Data from NYSE)
$8.45 USD
-0.35 (-3.98%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $8.39 -0.06 (-0.71%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.45 USD
-0.35 (-3.98%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $8.39 -0.06 (-0.71%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Zacks News
MultiPlan Corporation (MPLN) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
MultiPlan (MPLN) delivered earnings and revenue surprises of 21.94% and 0.18%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
MultiPlan Corporation (MPLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
MultiPlan (MPLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of 121.05% and 18.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in MultiPlan (MPLN): Can Its 9.0% Jump Turn into More Strength?
by Zacks Equity Research
MultiPlan (MPLN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MultiPlan Stock Falls Even After NRHA Rural Healthcare Deal
by Zacks Equity Research
MPLN and NRHA team up to empower rural healthcare providers with innovative technology and data-driven solutions, improving access, quality and affordability.
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CSML
Moving Average Crossover Alert: MultiPlan Corp (MPLN)
by Zacks Equity Research
MultiPlan Corporation (MPLN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front